Gene :: Key finding in rare muscle disease
A group of researchers has discovered a number of children suffering from rare muscle diseases whose bodies have “switched on” a gene that is usually turned off at birth.
A group of researchers has discovered a number of children suffering from rare muscle diseases whose bodies have “switched on” a gene that is usually turned off at birth.
Switching patients to more cost-effective drugs for cholesterol and blood pressure problems could reduce health budgets by billions without compromising clinical care, according to a study in the January issue of IJCP, the International Journal of Clinical Practice. No adverse events were reported after patients were switched — the new cholesterol drugs delivered the same results as the previous drug and the new blood pressure drugs delivered improved performance.
A new CAMH study showedsthat previously married mothers have higher rates of depressive disorders and alcohol abuse compared to married or never-married mothers. This work expands our understanding of the relationship between family structure and psychiatric outcomes, and enhances our understanding of how the pathway to single-motherhood impacts mental health.
CNRS (France) researchers have developed a novel synthetic process for bio degradeable materials that could be used instead of traditional medication in the form of tablets, capsules or syrups. This study was published on 27 December 2006 in the Journal of the American Chemical society.
Virginia Commonwealth University Massey Cancer Center researchers have identified an approach to enhance the activity of a new anti-cancer agent that has already shown impressive efficacy in the treatment of chronic myelogenous leukemia.
A surprising discovery by Queen’s University researchers that happened when their work took an unexpected turn may help women with advanced breast cancer respond better to conventional drug treatments.
A team of researchers from the CIMA of the University of Navarra has discovered a possible cause of thrombosis, and has developed a new diagnostic test for this disease. The scientific project was undertaken in the Hemostasis and Thrombosis Laboratory.
Researchers at Virginia Commonwealth University’s Massey Cancer Center have created a new method to improve the antileukemic activity of a novel agent that triggers programmed cell death, a development that could lead to more effective strategies for fighting leukemia and other malignancies.
Brain tumors appear to arise from cancer stem cells (CSCs) that live within microscopic protective “niches” formed by blood vessels in the brain; and disrupting these niches is a promising strategy for eliminating the tumors and preventing them from re-growing, according to results of a study by investigators at St. Jude Children’s Research Hospital. CSCs are cells that continually multiply, acting as the source of tumors.
Louise Brown, the world’s first test tube baby, has given birth to a child of her own – a boy. 28-year-old Louise, an administrative assistant, and her husband Wesley Mullinder, 37, were delighted at the safe arrival of the baby.